Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-11-16
Summary
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients with Non-segmental Vitiligo before and after phototherapy
Conditions
- Vitiligo
Interventions
- DIAGNOSTIC_TEST
-
Interleukin-15 and Interleukin-22
Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
More Related Trials
-
Dermoscopy in Nails
NCT06696612 ·Status: NOT_YET_RECRUITING
-
Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study
NCT06261086 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo
NCT06410898 ·Status: RECRUITING ·Phase: NA
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
NCT03249064 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis
NCT00509314 ·Status: UNKNOWN
-
Evaluation of Serological Markers of Vitiligo Activity
NCT06731283 ·Status: ACTIVE_NOT_RECRUITING
-
Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
NCT07058051 ·Status: COMPLETED
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
NCT04843059 ·Status: COMPLETED ·Phase: NA
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo
NCT05506995 ·Status: COMPLETED
-
Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NCT07187882 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
NCT06584643 ·Status: NOT_YET_RECRUITING
-
Photoprotection Habits in Patients With Vitiligo
NCT03323125 ·Status: COMPLETED
-
Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 ·Status: COMPLETED ·Phase: PHASE1